# MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial

> **NCT04698512** · — · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 35 (actual)

## Conditions studied

- Dialysis Access Malfunction
- End Stage Renal Failure on Dialysis
- End Stage Renal Disease
- Fistulas Arteriovenous
- Stenosis

## Interventions

- **DEVICE:** AVFistuloplasty with Sirolimus coated balloon

## Key facts

- **NCT ID:** NCT04698512
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-21
- **Primary completion:** 2020-01-16
- **Final completion:** 2021-01-30
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698512, "MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04698512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*